New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients: Editorial to: “Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High Density Lipoprotein” by E.J. Niesor et al.

Robert S. Rosenson; H. Bryan Brewer

doi:10.1007/s10557-015-6576-7

New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients: Editorial to: “Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High Density Lipoprotein” by E.J. Niesor et al.

Robert S. Rosenson
, H. Bryan Brewer

Research output: Contribution to journal › Editorial

7 Scopus citations

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Cardiovascular Drugs and Therapy
Volume	29
Issue number	1
DOIs	https://doi.org/10.1007/s10557-015-6576-7
State	Published - 7 Mar 2015

Access to Document

10.1007/s10557-015-6576-7

Cite this

Rosenson, R. S., & Brewer, H. B. (2015). New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients: Editorial to: “Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High Density Lipoprotein” by E.J. Niesor et al. Cardiovascular Drugs and Therapy, 29(1), 1-3. https://doi.org/10.1007/s10557-015-6576-7

Rosenson, Robert S. ; Brewer, H. Bryan. / New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients : Editorial to: “Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High Density Lipoprotein” by E.J. Niesor et al. In: Cardiovascular Drugs and Therapy. 2015 ; Vol. 29, No. 1. pp. 1-3.

@article{8cc346c300a14fa2aeb080005cfd0b80,

title = "New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients: Editorial to: “Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High Density Lipoprotein” by E.J. Niesor et al.",

author = "Rosenson, \{Robert S.\} and Brewer, \{H. Bryan\}",

year = "2015",

month = mar,

day = "7",

doi = "10.1007/s10557-015-6576-7",

language = "English",

volume = "29",

pages = "1--3",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Springer",

number = "1",

}

Rosenson, RS & Brewer, HB 2015, 'New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients: Editorial to: “Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High Density Lipoprotein” by E.J. Niesor et al.', Cardiovascular Drugs and Therapy, vol. 29, no. 1, pp. 1-3. https://doi.org/10.1007/s10557-015-6576-7

New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients: Editorial to: “Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High Density Lipoprotein” by E.J. Niesor et al. / Rosenson, Robert S.; Brewer, H. Bryan.
In: Cardiovascular Drugs and Therapy, Vol. 29, No. 1, 07.03.2015, p. 1-3.

Research output: Contribution to journal › Editorial

TY - JOUR

T1 - New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients

T2 - Editorial to: “Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High Density Lipoprotein” by E.J. Niesor et al.

AU - Rosenson, Robert S.

AU - Brewer, H. Bryan

PY - 2015/3/7

Y1 - 2015/3/7

UR - https://www.scopus.com/pages/publications/84953342929

U2 - 10.1007/s10557-015-6576-7

DO - 10.1007/s10557-015-6576-7

M3 - Editorial

C2 - 25702643

AN - SCOPUS:84953342929

SN - 0920-3206

VL - 29

SP - 1

EP - 3

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 1

ER -

Rosenson RS, Brewer HB. New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients: Editorial to: “Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High Density Lipoprotein” by E.J. Niesor et al. Cardiovascular Drugs and Therapy. 2015 Mar 7;29(1):1-3. doi: 10.1007/s10557-015-6576-7